Interim Management Statement

The European Investment Trust plc Interim Management Statement for the quarter ended 30 June 2014 The Board of The European Investment Trust plc ("the Company") announces its Interim Management Statement for the period from 1 April 2014 to 30 June 2014. This statement is required by the UK Listing Authority's Disclosure and Transparency Rules and should not be relied upon for any other purpose. Objective The objective of the Company is to achieve long-term capital growth through a diversified portfolio of Continental European securities. % Financial summary 30 June 2014 31 March 2014 Change Net assets £354.31m £360.28m -1.7 Net asset value ("NAV") per share 842.20p 856.40p -1.7 Share price 781.00p 773.00p 1.0 Share price discount to net asset 7.3% 9.7% value Investment Manager's review Performance During the quarter ended 30 June 2014, the NAV per share of the Company decreased from 856.40p to 842.20p, resulting in a total return of -1.7%. This compares with a total return of 0.3% in the FTSE All-World Europe ex UK Index in sterling. The Company's share price increased by 1.0% from 773.00p to 781.00p in the three month period and, as a consequence, the share price discount to NAV decreased from 9.7% to 7.3%. Review of markets Following significant rises in recent years, European stock markets stalled over the three months to 30 June 2014. This pause coincided with inconsistent economic news which, when combined with persistently low inflation, has led the European Central Bank to maintain a very accommodative monetary policy stance. Portfolio strategy There was a substantial increase in exposure to the health care sector. There are two reasons for this; the first is sector specific and the second, a rebalancing of the investment portfolio. We have become more positive on the underlying outlook for the sector. Following a long lean period in terms of productivity, the research and development departments of the pharmaceutical and biotech industry appear to be turning technological developments into healthy product pipelines again. When combined with increasing trends to specialisation in patient populations and disease categories, both industries could deliver healthy sales and profit growth over the next five to ten years. As at 30 June 2014 total exposure to the health care sector was 15.8%, a sharp increase from the 8.0% held at the start of the quarter. Recent purchases included Sanofi and Roche, in addition to which we increased the Company's existing holding in BB Biotech. BB Biotech is a Swiss based investment company which provides diversified exposure to the biotech industry, where stock specific risk can be very high. The company trades at a significant discount to its net asset value. The second reason for increasing health care exposure relates to a portfolio rebalancing. As stock markets have risen over the past few years many valuation imbalances have largely corrected and it is appropriate to start considering reducing exposure to companies with more cyclical or recovery characteristics, where shares are now viewed as being almost fully valued. Accordingly, investing in the health care sector, which we believe offers good long term value, makes sense from this perspective. Sources of funding for this increase in health care exposure have included the disposals of Swatch, the Swiss watch manufacturer and distributor, and Gazprom, the Russian energy group. Swatch has been a strong performer since purchase resulting, in our view, the shares becoming fully valued. Gazprom has been a disappointing investment since purchase and, after a reappraisal of its long term prospects, following a share price rally, the shares were sold. Outlook Although markets are currently trading at more demanding valuation levels, the accommodative stance from monetary authorities is likely to continue. We remain vigilant with regard to the valuation of individual companies within the portfolio, particularly their risk/reward profiles; however, at present, there is no reason to change from our fully invested stance. Gearing The Company announced, on 1 July 2014, that the Euro 30,000,000 secured multicurrency revolving loan facility agreement with Scotiabank Europe PLC would be cancelled with effect from 3 July 2014. Alternative Investment Fund Manager's Directive In order to comply with the Alternative Investment Fund Managers' Directive, on 18 July 2014, the Company appointed Edinburgh Partners AIFM Limited to act as its Alternative Investment Fund Manager ("AIFM"), and Northern Trust Global Services Limited to act as its Depositary. Custody services, which were previously supplied by JPMorgan Chase Bank, NA, are now being provided by The Northern Trust Company. The AIFM has delegated the function of managing the Company's investment portfolio to Edinburgh Partners Limited, the manager of the Company's assets since 1 February 2010. Portfolio of investments as at 30 June 2014 % of Ranking Company Sector Country Net Assets 1 Aryzta Consumer Goods Switzerland 3.1 2 PostNL Industrials Netherlands 3.0 3 Danske Bank Financials Denmark 3.0 4 Gerresheimer Health Care Germany 3.0 5 ENI Oil & Gas Italy 3.0 6 Volkswagen* Consumer Goods Germany 3.0 7 Valeo Consumer Goods France 3.0 8 Prysmian Industrials Italy 2.9 9 Roche Health Care Switzerland 2.9 10 Indra Sistemas Technology Spain 2.9 11 Piaggio Consumer Goods Italy 2.9 12 Belgacom Telecommunications Belgium 2.9 13 Royal Dutch Shell** Oil & Gas Netherlands 2.8 14 Novartis Health Care Switzerland 2.7 15 GAM Financials Switzerland 2.6 16 Delta Lloyd Financials Netherlands 2.5 17 BBVA Financials Spain 2.5 18 BB Biotech Health Care Switzerland 2.5 19 Sanofi Health Care France 2.5 20 GEA Industrials Germany 2.4 21 Ryanair Consumer Services Ireland 2.4 22 KPN Telecommunications Netherlands 2.4 23 Portugal Telecom Telecommunications Portugal 2.3 24 Orange Telecommunications France 2.3 25 Total Oil & Gas France 2.2 26 TDC Telecommunications Denmark 2.2 27 Vivendi Consumer Services France 2.2 28 Ahold Consumer Services Netherlands 2.2 29 Fresenius Medical Care Health Care Germany 2.2 30 Unipol Gruppo Financials Italy 2.1 31 BNP Paribas Financials France 2.1 32 Heineken Consumer Goods Netherlands 2.1 33 Pirelli Consumer Goods Italy 2.1 34 Swedbank Financials Sweden 2.0 35 SAP Technology Germany 2.0 36 Nutreco Consumer Goods Netherlands 2.0 37 Ipsos Consumer Services France 1.9 38 ABB Industrials Switzerland 1.9 39 Outotec Industrials Finland 1.9 40 Feintool International Industrials Switzerland 1.6 Total equity investments 98.2 Cash and other net assets 1.8 100.0 * The investment is in non-voting preference shares. ** The investment is in Class A ordinary shares. Sector distribution 30 June 2014 % of Net Assets Consumer Goods 18.2 Financials 16.8 Health Care 15.8 Industrials 13.7 Telecommunications 12.1 Consumer Services 8.7 Oil & Gas 8.0 Technology 4.9 Cash and other net 1.8 assets 100.0 Geographical distribution 30 June 2014 % of Net Assets Switzerland 17.3 Netherlands 17.0 France 16.2 Italy 13.0 Germany 12.6 Spain 5.4 Denmark 5.2 Belgium 2.9 Ireland 2.4 Portugal 2.3 Sweden 2.0 Finland 1.9 Cash and other net 1.8 assets 100.0 Further information Further information, including monthly factsheets and daily net asset values published since the end of the quarter, can be found on the Company's website: www.theeuropeaninvestmenttrust.com and the Edinburgh Partners' website: www.edinburghpartners.com. Past performance is not a guide to future performance. Other than as detailed above, the Board is not aware of any significant events or transactions that have occurred between 30 June 2014 and the date of publication of this statement which would have a material impact on the financial position of the Company. 13 August 2014 Enquiries: Dale Robertson Kenneth Greig Tel: 0131 270 3800 Alternative Investment Fund Manager: Edinburgh Partners AIFM Limited, 27-31 Melville Street, Edinburgh EH3 7JF Investment Manager: Edinburgh Partners Limited, 27-31 Melville Street, Edinburgh EH3 7JF Registered Office of the Company: Beaufort House, 51 New North Road, Exeter EX4 4EP Neither the contents of The European Investment Trust plc's website nor the contents of any website accessible from hyperlinks on the website (or any other website) is incorporated into, or forms part of, this announcement.
UK 100

Latest directors dealings